- Do Male Lymphoma Survivors Have Impaired Sexual Function?
[作者：Kiserud, CE; Schover, LR; Dahl, AA; Fossa, A; Bjoro, T; Loge, H; Holte, H; Yuan, Y; Fossa, SD,期刊：Journal of clinical oncology, 页码：6019-6026 , 文章类型： Article，,卷期：2009年27-35]
- Purpose Sexual function in male lymphoma survivors was examined and compared with that of age-matched controls. Patients and Methods This cross-sectional study included serum gonadal hormone levels (testosterone, sex hor...
- Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
[作者：Kim, SJ; Kim, K; Kim, BS; Kim, CY; Suh, C; Huh, J; Lee, SW; Kim, JS; Cho, J; Lee, GW; Kang, KM; Eom, HS; Pyo, HR; Ahn, YC; Ko, YH; Kim, WS,期刊：Journal of clinical oncology, 页码：6027-6032 , 文章类型： Article，,卷期：2009年27-35]
- Purpose On the basis of the benefits of frontline radiation in early-stage, extranodal, natural killer (NK)/T-cell lymphoma (ENKTL), we conducted a phase II trial of concurrent chemoradiotherapy (CCRT) followed by three ...
- One-Year Outcomes of a Behavioral Therapy Intervention Trial on Sleep Quality and Cancer-Related Fatigue
[作者：Berger, AM; Kuhn, BR; Farr, LA; Von Essen, SG; Chamberlain, J; Lynch, JC; Agrawal, S,期刊：Journal of clinical oncology, 页码：6033-6040 , 文章类型： Article，,卷期：2009年27-35]
- Purpose To determine 1-year outcomes of a four-component behavioral therapy (BT) sleep intervention (Individualized Sleep Promotion Plan [ISPP]) versus a healthy eating control (HEC) on cancer-related fatigue in women re...
- Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
[作者：Baccarani, M; Cortes, J; Pane, F; Niederwieser, D; Saglio, G; Apperley, J; Cervantes, F; Deininger, M; Gratwohl, A; Guilhot, F; Hochhaus, A; Horowitz, M; Hughes, T; Kantarjian, H; Larson, R; Radich, J; Simonsson, B; Silver, RT; Goldman, J; Hehlmann, R,期刊：Journal of clinical oncology, 页码：6041-6051 , 文章类型： Review，,卷期：2009年27-35]
- Purpose To review and update the European LeukemiaNet (ELN) recommendations for the management of chronic myeloid leukemia with imatinib and second-generation tyrosine kinase inhibitors (TKIs), including monitoring, resp...
- Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening-A Report From the American Society of Clinical Oncology
[作者：Petrelli, NJ; Winer, EP; Brahmer, J; Dubey, S; Smith, S; Thomas, C; Vahdat, LT; Obel, J; Vogelzang, N; Markman, M; Sweetenham, JW; Pfister, D; Kris, MG; Schuchter, LM; Sawaya, R; Raghavan, D; Ganz, PA; Kramer, B,期刊：Journal of clinical oncology, 页码：6052-6069 , 文章类型： Article，,卷期：2009年27-35]
-
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
[作者：Wick, W; Hartmann, C; Engel, C; Stoffels, M; Felsberg, J; Stockhammer, F; Sabel, MC; Koeppen, S; Ketter, R; Meyermann, R; Rapp, M; Meisner, C; Kortmann, RD; Pietsch, T; Wiestler, OD; Ernemann, U; Bamberg, M; Reifenberger, G; von Deimling, A; Weller, M,期刊：Journal of clinical oncology, 页码：5874-5880 , 文章类型： Article，,卷期：2009年27-35]
- Purpose The standard of care for anaplastic gliomas is surgery followed by radiotherapy. The NOA-04 phase III trial compared efficacy and safety of radiotherapy followed by chemotherapy at progression with the reverse se...
- Solitary Extramedullary Plasmacytoma of the Vocal Cord in an Adolescent
[作者：Vanan, I; Redner, A; Atlas, M; Marin, L; Kadkade, P; Bandovic, J; Jaffe, ES,期刊：Journal of clinical oncology, 页码：E244-E247 , 文章类型： Article，,卷期：2009年27-35]
-
- MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951
[作者：van den Bent, MJ; Dubbink, HJ; Sanson, M; van der Lee-Haarloo, CR; Hegi, M; Jeuken, JWM; Ibdaih, A; Brandes, AA; Taphoorn, MJB; Frenay, M; Lacombe, D; Gorlia, T; Dinjens, WNM; Kros, JM,期刊：Journal of clinical oncology, 页码：5881-5886 , 文章类型： Article，,卷期：2009年27-35]
- Purpose O6-methylguanine-methyltransferase (MGMT) promoter methylation has been shown to predict survival of patients with glioblastomas if temozolomide is added to radiotherapy (RT). It is unknown if MGMT promoter methy...
- Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
[作者：Graeser, MK; Engel, C; Rhiem, K; Gadzicki, D; Bick, U; Kast, K; Froster, UG; Schlehe, B; Bechtold, A; Arnold, N; Preisler-Adams, S; Nestle-Kraemling, C; Zaino, M; Loeffler, M; Kiechle, M; Meindl, A; Varga, D; Schmutzler, RK,期刊：Journal of clinical oncology, 页码：5887-5892 , 文章类型： Article，,卷期：2009年27-35]
- Purpose To estimate the risk for contralateral breast cancer in members of BRCA1- and BRCA2-positive families and to determine predictive risk factors. Patients and Methods A retrospective, multicenter, cohort study was ...
- Novel Breast Tissue Feature Strongly Associated With Risk of Breast Cancer
[作者：McKian, KP; Reynolds, CA; Visscher, DW; Nassar, A; Radisky, DC; Vierkant, RA; Degnim, AC; Boughey, JC; Ghosh, K; Anderson, SS; Minot, D; Caudill, JL; Vachon, CM; Frost, MH; Pankratz, VS; Hartmann, LC,期刊：Journal of clinical oncology, 页码：5893-5898 , 文章类型： Article，,卷期：2009年27-35]
- Purpose Accurate, individualized risk prediction for breast cancer is lacking. Tissue-based features may help to stratify women into different risk levels. Breast lobules are the anatomic sites of origin of breast cancer...
- Phase II Multicenter Trial of Anthracycline Rechallenge With Pegylated Liposomal Doxorubicin Plus Cyclophosphamide for First-Line Therapy of Metastatic Breast Cancer Previously Treated With Adjuvant Anthracyclines
[作者：Trudeau, ME; Clemons, MJ; Provencher, L; Panasci, L; Yelle, L; Rayson, D; Latreille, J; Vandenberg, T; Goel, R; Zibdawi, L; Rahim, Y; Pouliot, JF,期刊：Journal of clinical oncology, 页码：5906-5910 , 文章类型： Article，,卷期：2009年27-35]
- Purpose Anthracyclines are a component of breast cancer chemotherapy regimens in both adjuvant and metastatic settings. Anthracycline rechallenge for metastatic disease, for those previously exposed to adjuvant anthracyc...
- Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
[作者：Emens, LA; Asquith, JM; Leatherman, JM; Kobrin, BJ; Petrik, S; Laiko, M; Levi, J; Daphtary, MM; Biedrzycki, B; Wolff, AC; Stearns, V; Disis, ML; Ye, XB; Piantadosi, S; Fetting, JH; Davidson, NE; Jaffee, EM,期刊：Journal of clinical oncology, 页码：5911-5918 , 文章类型： Article，,卷期：2009年27-35]
- Purpose Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting tumor vaccines have demonstrated bioactivity but may be limited by disease burdens and immune tolerance. We tested the hypothesis that cyclophos...
- Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
[作者：Autier, P; Hery, C; Haukka, J; Boniol, M; Byrnes, G,期刊：Journal of clinical oncology, 页码：5919-5923 , 文章类型： Article，,卷期：2009年27-35]
- Purpose We assessed changes in advanced cancer incidence and cancer mortality in eight randomized trials of breast cancer screening. Patients and Methods Depending on published data, advanced cancer was defined as cancer...
|